Alnylam Pharmaceuticals, Inc.

Report date
9/30/2024
Quarter
2024 Q3
Filed
11/14/2024
Shares
8,405
Value ($000)
2,312
Weight
0.2%
2020 Q4 - 2024 Q3 (12 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).